Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Enora Laas Faron"'
Autor:
Laurence Slembrouck, Lauren Darrigues, Cecile Laurent, Lorenza Mittempergher, Leonie JMJ Delahaye, Isabelle Vanden Bempt, Sara Vander Borght, Liesbet Vliegen, Petra Sintubin, Virginie Raynal, Mylene Bohec, Cécile Reyes, Audrey Rapinat, Céline Helsmoortel, Lynn Jongen, Griet Hoste, Patrick Neven, Hans Wildiers, Ann Smeets, Ines Nevelsteen, Kevin Punie, Els Van Nieuwenhuysen, Sileny Han, Anne Vincent Salomon, Enora Laas Faron, Timothé Cynober, David Gentien, Sylvain Baulande, Mireille HJ Snel, Anke T Witteveen, Sari Neijenhuis, Annuska M Glas, Fabien Reyal, Giuseppe Floris
Publikováno v:
Translational Oncology, Vol 12, Iss 12, Pp 1557-1565 (2019)
A previously developed and centrally validated MammaPrint® (MP) and BluePrint® (BP) targeted RNA next-generation sequencing (NGS) kit was implemented and validated in two large academic European hospitals. Additionally, breast cancer molecular subt
Externí odkaz:
https://doaj.org/article/7dd90bdd8d2b401cbc180de9d3769d13
Autor:
Hans Wildiers, Cécile Reyes, Sileny Han, Lorenza Mittempergher, Timothé Cynober, F Reyal, Leonie J. M. J. Delahaye, Kevin Punie, Liesbet Vliegen, Ines Nevelsteen, Enora Laas Faron, Laurence Slembrouck, Petra Sintubin, Sara Vander Borght, G Hoste, Patrick Neven, Giuseppe Floris, Audrey Rapinat, Ann Smeets, Sylvain Baulande, Lynn Jongen, Mylène Bohec, Virginie Raynal, David Gentien, Céline Helsmoortel, Mireille Snel, Els Van Nieuwenhuysen, Lauren Darrigues, Isabelle Vanden Bempt, Anke T. Witteveen, Sari Neijenhuis, Cecile Laurent, Annuska M. Glas, Anne Vincent Salomon
Publikováno v:
Translational Oncology, Vol 12, Iss 12, Pp 1557-1565 (2019)
Translational Oncology
Translational Oncology
A previously developed and centrally validated MammaPrint® (MP) and BluePrint® (BP) targeted RNA next-generation sequencing (NGS) kit was implemented and validated in two large academic European hospitals. Additionally, breast cancer molecular subt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b312847395e353c90474276695b5c1
http://www.sciencedirect.com/science/article/pii/S1936523319303511
http://www.sciencedirect.com/science/article/pii/S1936523319303511
Autor:
Fabien Reyal, Bernard Asselain, Marie Osdoit, Jean Guillaume Feron, Vincent Balaya, Fatima Laki, Virginie Fourchotte, Fabrice Lecuru, Enora Laas Faron
Publikováno v:
Gynecologic oncology. 157(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46b3c76a1565ff6ee773895e4693878f
https://pubmed.ncbi.nlm.nih.gov/32334828
https://pubmed.ncbi.nlm.nih.gov/32334828
Autor:
Bresset, Arnaud
Publikováno v:
Médecine humaine et pathologie. 2019
Introduction - La prise en compte des délais de prise en charge en cancérologie est un critère de qualité. Nous ne connaissons pas leur impact sur la survie des patientes dans le cancer du sein et il existe peu de recommandations dans le cadre de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2592::ae3b7ebac45be06394dacbc4fe946fad
https://dumas.ccsd.cnrs.fr/dumas-03434350/document
https://dumas.ccsd.cnrs.fr/dumas-03434350/document
